CRP and COVID-19: Considering the insights derived from this RCT, we can affirm that oral NAC, when appropriately indicated, holds the potential to enhance oxygen saturation levels, temper the trajectory of inflammation (via CRP reduction), and contribute to a decrease in mortality risk among hospitalized COVID‐19 patients.